Evidence map›Paper›PMID 37628688›Full record

ArticleGenes2023

Refinement of

Alejandro Sánchez-Salvador, Sandra González-de la Fuente, Begoña Aguado, Phillip A Yates, Jose M Requena

Open access · goldAbstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Alejandro Sánchez-SalvadorCentro de Biología Molecular Severo Ochoa (CSIC-UAM), Departamento de Biología Molecular, Instituto Universitario de Biología Molecular (IUBM), Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0001-9002-3932
Sandra González-de la FuenteCentro de Biología Molecular Severo Ochoa (CSIC-UAM), Genomic and NGS Facility (GENGS), 28049 Madrid, Spain.ORCID 0000-0002-7470-2983
Begoña AguadoCentro de Biología Molecular Severo Ochoa (CSIC-UAM), Genomic and NGS Facility (GENGS), 28049 Madrid, Spain.ORCID 0000-0003-4043-6944
Phillip A YatesDepartment of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0003-2016-9789
Jose M RequenaCentro de Biología Molecular Severo Ochoa (CSIC-UAM), Departamento de Biología Molecular, Instituto Universitario de Biología Molecular (IUBM), Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0001-7550-0198
Centro de Biología Molecular Severo Ochoa · ESInstituto de Salud Carlos III · ESOregon Health & Science University · US

Funding

Generation and validation of a novel inducible overexpression library for genome-scale genetic screens in LeishmaniaR21AI166002 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI YATES, PHILLIP A · 2023 to 2024
$513k
NIAID NIH HHS R21 AI166002
6 · The paper itself

Abstract

Advances in next-generation sequencing methodologies have facilitated the assembly of an ever-increasing number of genomes. Gene annotations are typically conducted via specialized software, but the most accurate results require additional manual curation that incorporates insights derived from functional and bioinformatic analyses (e.g., transcriptomics, proteomics, and phylogenetics). In this study, we improved the annotation of the

Indexed as

Leishmania donovaniRibosome ProfilingGene Expression ProfilingRibosomesRNA, MessengerRNA, MessengergenomeLeishmaniaRibo-seqribosome profilingtranscriptomeuORFs

Identifiers

PMID37628688
PMCPMC10454037
OpenAlexW4385955155

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.